J. Michael Elliott

3.4k total citations · 1 hit paper
27 papers, 2.3k citations indexed

About

J. Michael Elliott is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, J. Michael Elliott has authored 27 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in J. Michael Elliott's work include Monoclonal and Polyclonal Antibodies Research (6 papers), Glycosylation and Glycoproteins Research (3 papers) and DNA Repair Mechanisms (3 papers). J. Michael Elliott is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), Glycosylation and Glycoproteins Research (3 papers) and DNA Repair Mechanisms (3 papers). J. Michael Elliott collaborates with scholars based in United States, United Kingdom and France. J. Michael Elliott's co-authors include Ryan J. Watts, Suzie J. Scales, Saileta Prabhu, Wilman Luk, Yin Zhang, Jasvinder K. Atwal, Yanmei Lu, Kwame Hoyte, Mark S. Dennis and Margaret Kenrick and has published in prestigious journals such as Science, Cell and Journal of Biological Chemistry.

In The Last Decade

J. Michael Elliott

27 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Boosting Brain Uptake of a Therapeutic Antibody by Reducing Its Affinity for a Transcytosis Target

2011 586 citations Yin Zhang, Margaret Kenrick et al. Science Translational Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Michael Elliott United States	22	1.2k	561	464	413	179	27	2.3k
Yingnan Zhang China	29	1.8k 1.5×	295 0.5×	318 0.7×	591 1.4×	167 0.9×	90	2.9k
Jennifer R. Allport United States	20	835 0.7×	559 1.0×	327 0.7×	384 0.9×	54 0.3×	25	2.2k
Clifford Quan United States	24	1.2k 1.0×	240 0.4×	405 0.9×	295 0.7×	163 0.9×	38	2.0k
Anna Maria Gasparri Italy	24	1.1k 0.9×	456 0.8×	692 1.5×	265 0.6×	232 1.3×	44	2.0k
Daniela Bumbaca United States	20	1.0k 0.8×	359 0.6×	735 1.6×	1.1k 2.6×	86 0.5×	29	2.2k
Masanobu Komatsu United States	28	1.7k 1.4×	457 0.8×	752 1.6×	457 1.1×	59 0.3×	66	2.9k
Oliver Hantschel Switzerland	36	3.0k 2.5×	577 1.0×	891 1.9×	544 1.3×	185 1.0×	71	5.7k
Hongmei Shen United States	23	1.5k 1.3×	955 1.7×	854 1.8×	237 0.6×	96 0.5×	48	3.1k
Flavio Curnis Italy	34	2.1k 1.8×	683 1.2×	1.5k 3.2×	565 1.4×	385 2.2×	79	3.9k
Frédéric Lopez France	25	1.3k 1.1×	603 1.1×	471 1.0×	181 0.4×	115 0.6×	46	2.6k

Countries citing papers authored by J. Michael Elliott

Since Specialization

Citations

This map shows the geographic impact of J. Michael Elliott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Michael Elliott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Michael Elliott more than expected).

Fields of papers citing papers by J. Michael Elliott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Michael Elliott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Michael Elliott. The network helps show where J. Michael Elliott may publish in the future.

Co-authorship network of co-authors of J. Michael Elliott

This figure shows the co-authorship network connecting the top 25 collaborators of J. Michael Elliott. A scholar is included among the top collaborators of J. Michael Elliott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Michael Elliott. J. Michael Elliott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Elliott, J. Michael, Mark Ultsch, Joshua Lee, et al.. (2014). Antiparallel Conformation of Knob and Hole Aglycosylated Half-Antibody Homodimers Is Mediated by a CH2–CH3 Hydrophobic Interaction. Journal of Molecular Biology. 426(9). 1947–1957. 31 indexed citations

Scheer, Justin M., Wendy Sandoval, J. Michael Elliott, et al.. (2012). Reorienting the Fab Domains of Trastuzumab Results in Potent HER2 Activators. PLoS ONE. 7(12). e51817–e51817. 32 indexed citations

Zhang, Yingnan, Lijuan Zhou, Monica Kong-Beltran, et al.. (2012). Calcium-Independent Inhibition of PCSK9 by Affinity-Improved Variants of the LDL Receptor EGF(A) Domain. Journal of Molecular Biology. 422(5). 685–696. 31 indexed citations

Stanger, Karen, Micah Steffek, Lijuan Zhou, et al.. (2012). Allosteric peptides bind a caspase zymogen and mediate caspase tetramerization. Nature Chemical Biology. 8(7). 655–660. 28 indexed citations

Lin, Kui, James R. Taylor, Thomas D. Wu, et al.. (2011). TMEFF2 Is a PDGF-AA Binding Protein with Methylation-Associated Gene Silencing in Multiple Cancer Types Including Glioma. PLoS ONE. 6(4). e18608–e18608. 38 indexed citations

Zhang, Yin, Margaret Kenrick, Kwame Hoyte, et al.. (2011). Boosting Brain Uptake of a Therapeutic Antibody by Reducing Its Affinity for a Transcytosis Target. Science Translational Medicine. 3(84). 84ra44–84ra44. 586 indexed citations breakdown →

Varfolomeev, Eugene, Bruno Alicke, J. Michael Elliott, et al.. (2009). X Chromosome-linked Inhibitor of Apoptosis Regulates Cell Death Induction by Proapoptotic Receptor Agonists. Journal of Biological Chemistry. 284(50). 34553–34560. 47 indexed citations

Elliott, J. Michael, Lionel Rougé, Christian Wiesmann, & Justin M. Scheer. (2009). Crystal Structure of Procaspase-1 Zymogen Domain Reveals Insight into Inflammatory Caspase Autoactivation. Journal of Biological Chemistry. 284(10). 6546–6553. 74 indexed citations

Stéphan, Jean-Philippe, Pamela Chan, Chien Lee, et al.. (2008). Anti-CD22-MCC-DM1 and MC-MMAF Conjugates: Impact of Assay Format on Pharmacokinetic Parameters Determination. Bioconjugate Chemistry. 19(8). 1673–1683. 53 indexed citations

10.

Ingle, Gladys S., Pamela Chan, J. Michael Elliott, et al.. (2007). High CD21 expression inhibits internalization of anti‐CD19 antibodies and cytotoxicity of an anti‐CD19‐drug conjugate. British Journal of Haematology. 140(1). 46–58. 61 indexed citations

11.

Manthey, Karoline C., Stephen O. Opiyo, Jason G. Glanzer, et al.. (2007). NBS1 mediates ATR-dependent RPA hyperphosphorylation following replication-fork stall and collapse. Journal of Cell Science. 120(23). 4221–4229. 37 indexed citations

12.

Appleton, B.A., Ping Wu, Janice Maloney, et al.. (2007). Structural studies of neuropilin/antibody complexes provide insights into semaphorin and VEGF binding. The EMBO Journal. 26(23). 4902–4912. 157 indexed citations

13.

Helmy, Karim Y., Kenneth J. Katschke, Nick N. Gorgani, et al.. (2006). CRIg: A Macrophage Complement Receptor Required for Phagocytosis of Circulating Pathogens. Cell. 124(5). 915–927. 446 indexed citations

14.

Quan, Clifford, Christian Wiesmann, Dan Sutherlin, et al.. (2006). Selective Inhibition of Fibroblast Activation Protein Protease Based on Dipeptide Substrate Specificity. Journal of Biological Chemistry. 281(11). 7437–7444. 1 indexed citations

15.

Robison, Jacob G., J. Michael Elliott, Kathleen Dixon, & Greg G. Oakley. (2004). Replication Protein A and the Mre11·Rad50·Nbs1 Complex Co-localize and Interact at Sites of Stalled Replication Forks. Journal of Biological Chemistry. 279(33). 34802–34810. 123 indexed citations

16.

Kirchhofer, Daniel, Mark Peek, Wei Li, et al.. (2003). Tissue Expression, Protease Specificity, and Kunitz Domain Functions of Hepatocyte Growth Factor Activator Inhibitor-1B (HAI-1B), a New Splice Variant of HAI-1. Journal of Biological Chemistry. 278(38). 36341–36349. 88 indexed citations

17.

Elliott, J. Michael, J. R. Chipperfield, Stephen Clark, & Ekkehard Sinn. (2002). Liquid crystal phase crossover (columnar↔calamitic) in polycatenar CuII 5-(3,4-dialkoxybenzylidine)aminotropololonates. Inorganic Chemistry Communications. 5(2). 99–101. 8 indexed citations

18.

Clark, Stephen, J. Michael Elliott, J. R. Chipperfield, Peter Styring, & Ekkehard Sinn. (2002). The first uranium based liquid crystals. Uranyl metallomesogens from β-diketone and tropolone ligands. Inorganic Chemistry Communications. 5(4). 249–251. 21 indexed citations

19.

Miller, Marian L., et al.. (1998). The morphological and spectral phenotype of apoptosis in HeLa cells varies following exposure to UV‐C and the addition of inhibitors of ICE and CPP32. Cell Proliferation. 31(1). 17–33. 6 indexed citations

20.

Chipperfield, J. R., Stephen Clark, J. Michael Elliott, & Ekkehard Sinn. (1998). New metallomesogens core. New copper complexes with calamitic mesophases using tropolone based ligands. Crystal structure of bis(5-octyloxytropolonato)copper. Chemical Communications. 195–196. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact